The abstract is read at the publisher; the summary is JClub's.
Triptonide alleviates sepsis-associated acute lung injury in LPS- and CLP-induced mice by suppressing macrophage STAT3/HIF-1α–linked aerobic glycolysis, improving septic survival.
- Why it matters: SA-ALI drives early hyperinflammatory mortality, and the mechanisms and therapeutic potential of triptonide in this setting are unclear.
- What they did: Mice received triptonide in LPS endotoxemia or CLP models, with parallel LPS-treated primary macrophage experiments; macrophage transcriptomics and metabolic analyses tested STAT3/HIF-1α involvement using inhibitors/activators and AAV targeting.
- The result: Triptonide reduced pulmonary inflammation and SA-ALI pathology, and its efficacy was abolished in myeloid cell–specific HIF-1α overexpressing LyzM-Cre DIO-hif1a mice, indicating dependence on the STAT3/HIF-1α axis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.